MALVERN, PA — HMP Global is set to host its first Lymphoma, Leukemia & Myeloma (LL&M) Winter Symposium, a pivotal event for healthcare professionals focusing on the latest in hematologic malignancies. Scheduled for February 7-9, 2025, at the Fontainebleau Miami Beach Hotel, this symposium aims to provide a comprehensive overview of cutting-edge clinical trial data, drug approvals, and advanced treatment strategies.
As the premier hematology meeting of the year, the symposium will feature insights from recent global hematology/oncology conferences. “The research on hematologic malignancies is constantly evolving,” noted Dr. Morton Coleman, Symposium Chair, highlighting the importance of staying abreast with the latest data and its implications for clinical practice.
Attendees will benefit from over 30 sessions led by more than 25 experts, covering crucial topics such as updates in basic science, leukemia, CLL, multiple myeloma, and lymphoma. These sessions are designed to translate scientific evidence into practical clinical applications, ultimately enhancing patient care.
Participants can earn up to 14 CME credits, reinforcing the symposium’s commitment to high-quality continuing education. This event is part of a broader educational initiative that includes the established LL&M Congress and the Great Debates in Hematologic Malignancies series, furthering HMP Global’s efforts to advance knowledge in hematologic oncology.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.